AMRScan: Dual-Mode Toolkit for AMR Detection
- AMRScan is a hybrid antimicrobial resistance gene detection toolkit implemented in R and Nextflow for rapid, reproducible analysis.
- It employs BLAST-based alignment against the CARD database followed by parsing to generate interpretable AMR hit summaries.
- The dual implementation offers a lightweight script for single-sample analysis and a modular workflow for scalable, high-performance batch processing.
AMRScan is a hybrid antimicrobial resistance gene detection toolkit implemented in both R and Nextflow for the rapid and reproducible detection of antimicrobial resistance genes from next-generation sequencing data. Its central operation is sequence alignment against antimicrobial-resistance reference databases—especially CARD—using BLAST, followed by parsing of the resulting hits into interpretable summaries. The toolkit is explicitly designed to bridge two use contexts: a concise, script-based mode suitable for single-sample analysis, teaching, and rapid prototyping, and a modular workflow mode intended for reproducible, scalable multi-sample processing in HPC and containerized environments (Lai, 10 Jul 2025).
1. Definition and design rationale
AMRScan is defined as a toolkit for detecting antimicrobial resistance genes from sequencing-derived sequence data by aligning those data to reference databases such as CARD and summarizing the resulting matches as putative AMR gene hits. The paper positions it as a response to a practical workflow problem rather than as a new AMR-detection algorithm. Existing platforms such as ResFinder are described as potentially powerful but also potentially resource-intensive or associated with complex installation and deployment requirements. AMRScan therefore emphasizes minimality, transparency, and reproducibility across small labs, clinical settings, research groups, and large-scale public health genomics workflows (Lai, 10 Jul 2025).
The paper’s conceptual contribution is the coexistence of two parallel implementations of the same analytical strategy. One is deliberately linear and lightweight; the other is modular and orchestration-oriented. This duality is the core of the system’s identity. Rather than choosing between an exploratory script and a production workflow, AMRScan presents them as complementary interfaces to the same BLAST-based detection logic.
A recurrent misconception would be to treat AMRScan as a new resistance-inference model comparable to machine-learning predictors of phenotype or evolutionary simulators. The paper does not support that reading. Its novelty lies in implementation design, modularization, and usability, with shared parsing logic intended to keep outputs consistent across both operating modes (Lai, 10 Jul 2025).
2. Dual implementation model
AMRScan is distributed in two explicit forms: an R-based standalone script and a Nextflow workflow. The paper identifies the main files as scripts/AMRScan_standalone.R, scripts/parse_blast.R, and workflow/main.nf (Lai, 10 Jul 2025).
| Implementation | Primary use | Principal components |
|---|---|---|
| R standalone | Single-sample analysis, teaching, rapid prototyping | scripts/AMRScan_standalone.R, shared scripts/parse_blast.R |
| Nextflow workflow | Multi-sample batch processing, HPC, containerized deployment | workflow/main.nf, DownloadCARD, MakeBLASTdb, ConvertFASTQ, RunBLAST, ParseResults |
The R implementation is described as a linear script-based format that encapsulates the entire pipeline. It is intended for small datasets, quick local tests, educational use, lightweight environments without workflow managers, and rapid prototyping. Its main strengths are transparency, low barrier to entry, and ease of inspection and modification. By contrast, its limitations are mostly implicit: it is not presented as the preferred mode for large batch processing, HPC, cloud-scale analysis, or highly automated production workflows (Lai, 10 Jul 2025).
The Nextflow implementation is the production-oriented counterpart. It organizes the pipeline into named modules—DownloadCARD, MakeBLASTdb, ConvertFASTQ, RunBLAST, and ParseResults—and is presented as reproducible, scalable, modular, and suitable for multi-sample settings, HPC, cloud execution, and containerized environments. The paper also emphasizes parallelism and automated database setup as central advantages of this version (Lai, 10 Jul 2025).
This two-tier structure makes the toolkit unusual among small AMR utilities. The same core detection strategy is exposed through both a transparent script and a workflow engine, with a shared parser to preserve output consistency.
3. Analytical workflow
The AMRScan workflow begins with sequence data and ends with a parsed AMR hit summary. The paper states that the toolkit targets NGS data and that the Nextflow implementation includes a ConvertFASTQ step, which establishes explicit support for FASTQ input at least in the workflow version. At the same time, the demonstration case uses an assembled genome downloaded from GenBank—accession GCA_037966445.1, a multidrug-resistant Klebsiella pneumoniae assembly from Munim et al. (2024)—showing that assembly-derived sequence records can also serve as BLAST queries (Lai, 10 Jul 2025).
Database preparation is one of the most concretely specified components. The emphasized reference database is the Comprehensive Antibiotic Resistance Database, and the demonstration uses the CARD protein homolog model, Broadstreet version 4.0.1, with the URL https://card.mcmaster.ca/download/0/broadstreet-v4.0.1.tar.bz2. In the workflow implementation, DownloadCARD retrieves the reference data and MakeBLASTdb formats them into a BLAST database (Lai, 10 Jul 2025).
The central detection step is BLAST alignment. The paper states that AMRScan identifies AMR gene hits by aligning input sequences against CARD or similar AMR reference databases using BLAST, then parsing the resulting hits. However, the manuscript does not specify the BLAST flavor, custom alignment options, identity cutoff, coverage threshold, e-value threshold for acceptance, or tie-breaking rule among multiple hits. This is a major boundary on methodological specificity: the workflow is clear, but the exact decision criteria are not formally documented (Lai, 10 Jul 2025).
Post-alignment parsing is handled through the shared R script scripts/parse_blast.R. The output is not raw BLAST text alone but a summarized hit table. The paper indicates that the parser extracts at least the fields Query, Subject, Identity, Length, Evalue, Bitscore, and Annotation. The example “Top AMR Hits Summary” includes entries such as LAP-2 with identity 100.000, length 285, e-value 0, bitscore 587; SHV-11 with identity 100.000, length 286, e-value 0, bitscore 581; and dfrA14 with identity 98.726, length 157, e-value 0, bitscore 327 (Lai, 10 Jul 2025).
The phrase “Top AMR Hits Summary” suggests that hits are ranked or selected, but the paper does not describe the exact ranking or selection rule. Likewise, although quality control is mentioned as part of the workflow, the exact QC software, QC metrics, and filtering rules are not documented in the manuscript.
4. Software organization, reproducibility, and execution environments
AMRScan’s reproducibility model rests primarily on explicit workflow structuring and shared components rather than on formal benchmarking. The Nextflow workflow decomposes the analysis into named modules, while both implementations reuse parse_blast.R for post-BLAST summarization. The paper states that this shared logic is intended to ensure consistency and reproducibility of results across the R and Nextflow versions (Lai, 10 Jul 2025).
The explicitly named software dependencies are R, Nextflow, BLAST, and the CARD database. The execution environments explicitly mentioned are local lightweight environments, HPC, cloud, and containerized environments. Parallelism is claimed as a feature of the Nextflow implementation, although the paper does not provide scheduler-specific details, speedup measurements, or workflow-profile examples (Lai, 10 Jul 2025).
The repository is given as https://github.com/biosciences/AMRScan. The manuscript also states that both implementations are documented, testable, and validated using mock NGS input. At the same time, it does not provide step-by-step installation commands, explicit command-line invocation examples, parameter-setting examples, or a function-level R API. The R version is framed as a standalone script rather than as an R package with exported functions (Lai, 10 Jul 2025).
Containerization is emphasized conceptually, but no container engine is named. Likewise, HPC suitability is asserted, but no scheduler integration or resource model is described. The result is a toolkit whose workflow-level intent is clear while some operational details remain repository-dependent rather than manuscript-specified.
5. Demonstration case and output interpretation
The paper includes a real-world demonstration using a multidrug-resistant Klebsiella pneumoniae genome assembly from poultry in Noakhali, Bangladesh, accession GCA_037966445.1, analyzed against the CARD Broadstreet v4.0.1 protein homolog model. The sample output identifies several AMR-related hits, including LAP-2, SHV-11, eptB, dfrA14, OprA, and YojI, each associated with identity, alignment length, e-value, bitscore, and annotation fields (Lai, 10 Jul 2025).
These outputs illustrate the intended semantics of an AMRScan result: each row links a query sequence to a known AMR-related entry in the reference database, with alignment statistics supporting the match. The manuscript further notes that higher identity, lower e-value, and higher bitscore support stronger similarity, although it does not convert those quantities into formal acceptance thresholds (Lai, 10 Jul 2025).
Interpretively, the demonstration shows that AMRScan can recover plausible AMR-associated genes from an assembled bacterial genome. What it does not show is quantitative performance in the benchmarking sense. The paper does not provide runtime measurements, memory use, throughput metrics, sensitivity/specificity estimates, reproducibility experiments across repeated runs, or formal comparisons with established tools such as ResFinder. The claims of speed, portability, and reproducibility are therefore supported mainly by architectural design and example use rather than by extensive quantitative evaluation (Lai, 10 Jul 2025).
This distinction is important. The demonstration establishes operational plausibility and output structure, not comparative diagnostic superiority.
6. Position within the broader AMR informatics landscape
Within the broader antimicrobial-resistance informatics landscape, AMRScan occupies the sequence-alignment layer of AMR analysis rather than the entire analytics stack. A broader review of AMR data science describes effective AMR systems as requiring surveillance, harmonization, prediction, stewardship support, driver analysis, and governance, with heterogeneous inputs spanning genomics, microbiology, EHRs, antimicrobial-use data, and One Health surveillance streams (Fu et al., 30 Jan 2025). AMRScan addresses only one portion of that ecosystem: sequence-based identification of resistance-associated genes from NGS-derived data.
This positioning distinguishes it from phenotype-centered resources and systems. For example, ARMD is an EHR-derived microbiology dataset centered on cultures, antibiotic susceptibilities, organism identification, and linked clinical context, supporting empiric-therapy modeling and stewardship-oriented prediction (Haredasht et al., 8 Mar 2025). AMRScan does not operate in that clinical-culture space; it operates upstream or alongside it, at the level of sequence-to-reference matching.
It is also distinct from phenotypic antimicrobial susceptibility testing platforms. Automated optical AST systems based on broth microdilution seek early growth/no-growth determination and MIC/susceptibility inference from incubated plates (Brown et al., 2020). AMRScan, by contrast, is BLAST-based and genotype-oriented. It does not estimate MICs, model organism growth, or replace AST workflows. A plausible implication is that it is most naturally used either for genomic surveillance or as one module within a larger AMR analytics framework that also includes phenotypic and clinical data.
The broader AMR review also emphasizes that ARG databases such as CARD are foundational yet imperfect reference resources, with integration and annotation quality being recurring concerns (Fu et al., 30 Jan 2025). This suggests that database versioning and provenance are not incidental implementation details for AMRScan but central determinants of reproducibility and interpretability.
7. Limitations, interpretive cautions, and likely development paths
The manuscript is explicit about several limitations. It does not provide explicit BLAST parameterization, identity or coverage cutoffs, e-value decision thresholds, overlap-handling rules, or formal hit-scoring equations. It does not report command-line examples, installation commands, container-engine details, HPC scheduler integration, or a formal interpretation guide for output tables. It also lacks runtime benchmarking, memory analysis, scaling curves, accuracy comparisons against gold standards, and direct quantitative comparison with other AMR detection tools (Lai, 10 Jul 2025).
These omissions constrain exact reproducibility from the paper alone. The workflow architecture can be reconstructed at a high level, but not every operational detail can be faithfully rebuilt from the manuscript. The same applies to evaluation: the paper establishes that AMRScan is documented, testable, and validated using mock NGS input, and that it produces interpretable AMR hit summaries, but it does not establish formal detection-performance characteristics in the way expected of benchmark-driven method papers (Lai, 10 Jul 2025).
The paper nonetheless implies several development directions. Fuller benchmarking against tools such as ResFinder, explicit thresholding and reporting criteria, expanded database support, richer documentation of QC and output interpretation, and quantitative evaluation of scalability and reproducibility would all strengthen the toolkit’s scientific characterization. This suggests that AMRScan’s present significance lies primarily in workflow accessibility, translational usability, and dual-mode deployment design rather than in a newly formalized AMR gene inference method (Lai, 10 Jul 2025).
In that sense, AMRScan is best understood as a lightweight-to-scalable infrastructure layer for AMR gene detection from sequencing data: a toolkit that operationalizes a familiar BLAST-against-reference workflow across both script-based and workflow-managed environments, while leaving several methodological and benchmarking questions open for future refinement.
